Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
468 | 24157 | 39.0 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
468 | 3 | GLUCOSINOLATES//BILIRUBIN//HEME OXYGENASE | 24157 |
1296 | 2 | HEME OXYGENASE//PORPHYRIA//HEME OXYGENASE 1 | 8624 |
1434 | 2 | BILIRUBIN//HYPERBILIRUBINEMIA//KERNICTERUS | 7874 |
2122 | 2 | GLUCOSINOLATES//SULFORAPHANE//ISOTHIOCYANATES | 5091 |
2994 | 2 | NRF2//KEAP1//ANTIOXIDANT RESPONSE ELEMENT | 2568 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLUCOSINOLATES | authKW | 681503 | 4% | 58% | 937 |
2 | BILIRUBIN | authKW | 551527 | 4% | 51% | 858 |
3 | HEME OXYGENASE | authKW | 539687 | 3% | 55% | 777 |
4 | NRF2 | authKW | 517901 | 4% | 42% | 977 |
5 | SULFORAPHANE | authKW | 472638 | 2% | 74% | 507 |
6 | HEME OXYGENASE 1 | authKW | 326320 | 3% | 37% | 700 |
7 | HYPERBILIRUBINEMIA | authKW | 297389 | 2% | 57% | 413 |
8 | PORPHYRIA | authKW | 277063 | 1% | 73% | 299 |
9 | KERNICTERUS | authKW | 217913 | 1% | 87% | 198 |
10 | ISOTHIOCYANATES | authKW | 217233 | 2% | 39% | 440 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 11661 | 22% | 0% | 5273 |
2 | Pharmacology & Pharmacy | 8314 | 13% | 0% | 3182 |
3 | Pediatrics | 7567 | 7% | 0% | 1702 |
4 | Toxicology | 3767 | 5% | 0% | 1088 |
5 | Food Science & Technology | 3714 | 6% | 0% | 1359 |
6 | Medical Laboratory Technology | 3383 | 2% | 1% | 535 |
7 | Medicine, Research & Experimental | 1955 | 5% | 0% | 1100 |
8 | Oncology | 1751 | 7% | 0% | 1595 |
9 | Biophysics | 1508 | 4% | 0% | 966 |
10 | Dermatology | 1404 | 2% | 0% | 571 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FRANCAIS PORPHYRIES | 63449 | 0% | 77% | 65 |
2 | PORPHYRIA SWEDEN | 34645 | 0% | 89% | 31 |
3 | LEWIS B DOROTHY CULLMAN CANC CHEMOPROTECT | 27049 | 0% | 79% | 27 |
4 | VASC BIOL UNIT | 23259 | 0% | 22% | 86 |
5 | DYNAMO EXCELLENCE | 20177 | 0% | 67% | 24 |
6 | JOINT TRANSLAT MED | 19059 | 0% | 66% | 23 |
7 | PORPHYRIA | 18580 | 0% | 82% | 18 |
8 | ENVIRONM PONSE PROJECT | 18323 | 0% | 58% | 25 |
9 | NEONATAL DEV MED | 15328 | 0% | 19% | 64 |
10 | IST SPERIMENTALE COLTURE IND | 14017 | 0% | 65% | 17 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 20504 | 1% | 5% | 354 |
2 | ANTIOXIDANTS & REDOX SIGNALING | 9828 | 1% | 5% | 157 |
3 | FREE RADICAL BIOLOGY AND MEDICINE | 8833 | 1% | 3% | 251 |
4 | LATIN AMERICAN JOURNAL OF PHARMACY | 7054 | 0% | 5% | 118 |
5 | BIOCHEMICAL PHARMACOLOGY | 6158 | 1% | 2% | 313 |
6 | MONATSHEFTE FUR CHEMIE | 4601 | 1% | 3% | 154 |
7 | BIOLOGY OF THE NEONATE | 3975 | 0% | 4% | 92 |
8 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 3742 | 0% | 4% | 72 |
9 | PEDIATRICS | 3521 | 1% | 1% | 244 |
10 | DRUG METABOLISM AND PHARMACOKINETICS | 3461 | 0% | 6% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCOSINOLATES | 681503 | 4% | 58% | 937 | Search GLUCOSINOLATES | Search GLUCOSINOLATES |
2 | BILIRUBIN | 551527 | 4% | 51% | 858 | Search BILIRUBIN | Search BILIRUBIN |
3 | HEME OXYGENASE | 539687 | 3% | 55% | 777 | Search HEME+OXYGENASE | Search HEME+OXYGENASE |
4 | NRF2 | 517901 | 4% | 42% | 977 | Search NRF2 | Search NRF2 |
5 | SULFORAPHANE | 472638 | 2% | 74% | 507 | Search SULFORAPHANE | Search SULFORAPHANE |
6 | HEME OXYGENASE 1 | 326320 | 3% | 37% | 700 | Search HEME+OXYGENASE+1 | Search HEME+OXYGENASE+1 |
7 | HYPERBILIRUBINEMIA | 297389 | 2% | 57% | 413 | Search HYPERBILIRUBINEMIA | Search HYPERBILIRUBINEMIA |
8 | PORPHYRIA | 277063 | 1% | 73% | 299 | Search PORPHYRIA | Search PORPHYRIA |
9 | KERNICTERUS | 217913 | 1% | 87% | 198 | Search KERNICTERUS | Search KERNICTERUS |
10 | ISOTHIOCYANATES | 217233 | 2% | 39% | 440 | Search ISOTHIOCYANATES | Search ISOTHIOCYANATES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RYTER, SW , ALAM, J , CHOI, AMK , (2006) HEME OXYGENASE-1/CARBON MONOXIDE: FROM BASIC SCIENCE TO THERAPEUTIC APPLICATIONS.PHYSIOLOGICAL REVIEWS. VOL. 86. ISSUE 2. P. 583 -650 | 470 | 70% | 1163 |
2 | RYTER, SW , CHOI, AMK , (2016) TARGETING HEME OXYGENASE-1 AND CARBON MONOXIDE FOR THERAPEUTIC MODULATION OF INFLAMMATION.TRANSLATIONAL RESEARCH. VOL. 167. ISSUE 1. P. 7 -34 | 278 | 83% | 13 |
3 | ABRAHAM, NG , KAPPAS, A , (2008) PHARMACOLOGICAL AND CLINICAL ASPECTS OF HEME OXYGENASE.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 1. P. 79 -127 | 361 | 63% | 508 |
4 | FIMOGNARI, C , TURRINI, E , FERRUZZI, L , LENZI, M , HRELIA, P , (2012) NATURAL ISOTHIOCYANATES: GENOTOXIC POTENTIAL VERSUS CHEMOPREVENTION.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 750. ISSUE 2. P. 107 -131 | 395 | 74% | 34 |
5 | WU, LY , WANG, R , (2005) CARBON MONOXIDE: ENDOGENOUS PRODUCTION, PHYSIOLOGICAL FUNCTIONS, AND PHARMACOLOGICAL APPLICATIONS.PHARMACOLOGICAL REVIEWS. VOL. 57. ISSUE 4. P. 585 -630 | 329 | 71% | 380 |
6 | LOBODA, A , JAZWA, A , GROCHOT-PRZECZEK, A , RUTKOWSKI, AJ , CISOWSKI, J , AGARWAL, A , JOZKOWICZ, A , DULAK, J , (2008) HEME OXYGENASE-1 AND THE VASCULAR BED: FROM MOLECULAR MECHANISMS TO THERAPEUTIC OPPORTUNITIES.ANTIOXIDANTS & REDOX SIGNALING. VOL. 10. ISSUE 10. P. 1767 -1812 | 344 | 76% | 106 |
7 | AYER, A , ZARJOU, A , AGARWAL, A , STOCKER, R , (2016) HEME OXYGENASES IN CARDIOVASCULAR HEALTH AND DISEASE.PHYSIOLOGICAL REVIEWS. VOL. 96. ISSUE 4. P. 1449 -1508 | 365 | 61% | 1 |
8 | BAIRD, L , DINKOVA-KOSTOVA, AT , (2011) THE CYTOPROTECTIVE ROLE OF THE KEAP1-NRF2 PATHWAY.ARCHIVES OF TOXICOLOGY. VOL. 85. ISSUE 4. P. 241 -272 | 222 | 66% | 266 |
9 | MOTTERLINI, R , OTTERBEIN, LE , (2010) THE THERAPEUTIC POTENTIAL OF CARBON MONOXIDE.NATURE REVIEWS DRUG DISCOVERY. VOL. 9. ISSUE 9. P. 728 -U24 | 150 | 89% | 375 |
10 | KUMAR, H , KIM, IS , MORE, SV , KIM, BW , CHOI, DK , (2014) NATURAL PRODUCT-DERIVED PHARMACOLOGICAL MODULATORS OF NRF2/ARE PATHWAY FOR CHRONIC DISEASES.NATURAL PRODUCT REPORTS. VOL. 31. ISSUE 1. P. 109 -139 | 263 | 61% | 42 |
Classes with closest relation at Level 3 |